Alzheimer's disease affects more than 6 million Americans, and aging remains its greatest risk factor. While current treatments can slow progression, none stop the disease. Intriguingly, large studies of patient records suggest that people who take a common class of blood pressure medication — calcium channel blockers — develop less Alzheimer's pathology and maintain better cognitive function than those who don't. But how?
In this talk, Dr. Sarah Hopp will explain how her lab at UT Health San Antonio is working to answer that question. Using a combination of patient data, genetically engineered mouse models of Alzheimer's disease, and genetic tools that can switch off specific calcium channels in specific cell types, her team is uncovering how these widely prescribed drugs may protect the brain. Dr. Hopp will discuss what this means for the future of Alzheimer's prevention and the growing interest in repurposing existing medications for neurodegenerative disease
Registration details:
Seating goes to those who register via this vtools event in the order received; plan ahead to REGISTER.
Registration Fees:
At the door, there is a $20.00 fee for Members, $30.00 for Guests and $5.00 for Students. We accept Cash or Check, no credit cards. Exact amounts preferable. Remainder of the tab will be picked up by the EMB.
Speaker(s): Sarah,
Agenda:
11:00 – Arrival
11:30 – Lunch and presentation
12:30 – Q and A
13:00 – Adjourn
Room: Mission Room, Alamo Cafe (Hwy 281), 14250 San Pedro Ave,, San Antonio, Texas, United States, 78232
